Abstract
Predicting molecular interactions is a major goal in rational drug design. Pharmacophore, which is the spatial arrangement of features that is essential for a molecule to interact with a specific target receptor, is an important model for achieving this goal. We present a freely available web server, named PharmaGist, for pharmacophore detection. The employed method is ligand based. Namely, it does not require the structure of the target receptor. Instead, the input is a set of structures of drug-like molecules that are known to bind to the receptor. The output consists of candidate pharmacophores that are computed by multiple flexible alignment of the input ligands. The method handles the flexibility of the input ligands explicitly and in deterministic manner within the alignment process. PharmaGist is also highly efficient, where a typical run with up to 32 drug-like molecules takes seconds to a few minutes on a stardard PC. Another important characteristic is the capability of detecting pharmacophores shared by different subsets of input molecules. This capability is a key advantage when the ligands belong to different binding modes or when the input contains outliers. The webserver has a user-friendly interface available at http://bioinfo3d.cs.tau.ac.il/PharmaGist.
| Original language | English |
|---|---|
| Pages (from-to) | W223-228 |
| Journal | Nucleic Acids Research |
| Volume | 36 |
| Issue number | Web Server issue |
| DOIs | |
| State | Published - 1 Jul 2008 |
| Externally published | Yes |
Bibliographical note
Funding Information:We want to thank D. Fishlovitch, A. Oron and H. Senderowitz for useful advises. The research of O.D. and Y.I. has been supported by the Eshkol Fellowship funded by the Israeli Ministry of Science. The research of H.J.W. has been supported in part by the Israel Science Foundation (grant no. 281/05) and by the Hermann Minkowski-Minerva Center for Geometry at TAU. The research of H.J.W. and R.N. has been by the NIAID, NIH (grant No. 1UC1AI067231), and by the Binational US-Israel Science Foundation (BSF). This project has been funded in whole or in part with Federal funds from the National Cancer Institute, National Institutes of Health, under contract number N01-CO-12400.